Cosmos Health (NASDAQ:COSM) Shares Down 6.4% – Time to Sell?

Cosmos Health Inc. (NASDAQ:COSMGet Free Report) was down 6.4% on Monday . The company traded as low as $0.73 and last traded at $0.74. Approximately 101,312 shares were traded during trading, a decline of 89% from the average daily volume of 896,818 shares. The stock had previously closed at $0.79.

Cosmos Health Trading Down 1.7 %

The company has a debt-to-equity ratio of 0.07, a current ratio of 1.35 and a quick ratio of 1.17. The firm’s fifty day moving average is $0.98 and its 200-day moving average is $0.89. The firm has a market cap of $12.53 million, a price-to-earnings ratio of -0.33 and a beta of 5.70.

Cosmos Health (NASDAQ:COSMGet Free Report) last released its earnings results on Tuesday, August 20th. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.05. The business had revenue of $13.21 million during the quarter, compared to analysts’ expectations of $15.25 million. Cosmos Health had a negative return on equity of 5.83% and a negative net margin of 38.19%. Equities analysts anticipate that Cosmos Health Inc. will post -0.48 earnings per share for the current year.

About Cosmos Health

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.

Featured Articles

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.